JNJ: JNJ4804 Despite likely efficacy, maintenance Rx concerns over combo in UC

Ahead of the imminent JNJ4804 DUET dual therapy IL23/TNF Ulcerative Colitis /Crohn’s trials (estimated completion last month), our in-depth combo report highlights several concerns of a fixed dose preparation for maintenance use despite the success of the initial VEGA induction combination trial and our expectation of a likely positive efficacy headline.…